Musk’s Neuralink to conduct trials at UAE’s Cleveland Clinic

Elon Musk’s Neuralink will team up with the Cleveland Clinic Abu Dhabi to conduct the first clinical trials of its brain-chip technology outside America.

Neuralink’s futuristic chip is a brain-computer interface technology which is designed to improve the lives of paralysed patients by helping them control a computer by thought.

So far, it has only been tested on three people in the U.S. The trial program, to be called UAE-PRIME, was announced by the Department of Health Abu Dhabi on Wednesday, ahead of the arrival in the UAE of U.S. President Donald Trump and his billionaire-heavy delegation, which includes Musk.

Health Department chairman Mansoor Ibrahim Al Mansoori said the trial marked a significant step in developing life sciences in the region.

“In collaboration with Cleveland Clinic Abu Dhabi, we are proud to enable the safe and responsible advancement of brain-computer interface technology, offering renewed hope to individuals living with severe neurological conditions,” Al Mansoori said.

Abu Dhabi is actively positioning itself as a launchpad for global health innovation and has been seeking further U.S. support for its newly announced $25.6 billion health cluster.